American Airlines Group Inc vs McKesson Corporation — how do they compare? American Airlines Group Inc trades at $15.44 (market cap $10.55B), while McKesson Corporation trades at $894.99 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 10× American Airlines Group Inc's market cap, and McKesson Corporation pays a 0.42% dividend while American Airlines Group Inc pays none. Which is the better fit depends on your goals.
| AAL | MCK | |
|---|---|---|
Market Cap | $10.55B | $105.14B |
Sector | Industrials | Health |
52-Week High | $18.15 | $995.69 |
52-Week Low | $10.18 | $659.01 |
Enterprise Value | $38.51B | $111.67B |
Dividend Yield | — | 0.42% |
Signals from Pluang's Aura AI — not financial advice
AAL trades at $15.00, down 5.9% in the last 24 hours, with technical indicators signaling a bearish trend near support at $14. The company reported mixed earnings, beating estimates in Q1 and Q2 2026 but missing in Q4 2025, with revenue growth to $54.63 billion in 2025. However, net income margin remains negative at -0.56%, and high debt levels persist despite a declining trend.
AAL's outlook is cautious; while analyst consensus is a buy with a $19.63 price target, risks include volatile fuel costs, leverage, and thin profitability. The stock offers potential upside if premium revenue growth sustains, but investors face headwinds from operational margins and economic sensitivity.
No Aura AI signal available yet.
Trailing returns across standard periods
American Airlines is the world's largest airline by scheduled revenue passenger miles. The firm's major hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. After completing a major fleet renewal, the company has the youngest fleet of U.S. legacy carriers.
Read more on AAL →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →